Is Devonian Health Group Inc. (DVHGF) a Buy, Sell, or Hold?
OTC : DVHGF
Devonian Health Group Inc.
$7 USD
$0 (0.0%)
- Volume
- 100
- Average Volume
- 1
- Market Capitalization
- $19.47M
- P/E Ratio
- -4.49
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $10.80
- Year Low
- $4.27
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.91
| Source | Headline |
|---|---|
|
Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026
Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026 PR Newswire gurufocus.com - 2026-06-29 21:00:00 |
|
Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026
(all amounts are in Canadian dollars) Quarter ended April 30, 2026, net loss of $1.9 million dollars, ($0.70) per share Nine months ended April 30, 2026, net loss of $5.7 million dollars, ($2.07) per share Cash as of April 30, 2026, $0.7 million Company remains debt-free QUÉBEC, June 29, 2026 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today highlighted its financial and operating results for the three and nine months ended April 30, 2026. ''We are pleased with the continued momentum to execute on our priorities and readiness to advance our pipeline'', said Dr. André P. prnewswire.com - 2026-06-29 20:00:00 |
